Semagacestat (LY450139) Catalog No.:M7908-10 Chronic intrathecal infusion of T-type

Chronic intrathecal infusion of T-type calcium channel blockers attenuates CaV3

and gastrointestinal tract

macrophages acquire resistance to infection and enhanced antileishmanial activity through the NO synthase pathway

Linezolid inhibits protein synthesis by binding to domain V of the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes

6'-dichlorophenylamino)-2-imidazoline

Semagacestat (LY450139) Catalog No.:M7908-10 Chronic intrathecal infusion of T-typeSemagacestat, also known as LY450139 or LY4501; was a candidate drug for a causal therapy against Alzheimer's disease. Product information CAS Number: 425386 60 3 Molecular Weight: 361. 44 Formula: C19H27N3O4 Synonym: LY 4501 Chemical Name: (S) 2 hydroxy 3 methyl N ((S) 1 (((S) 3 methyl 2 oxo 2, 3, 4, 5 tetrahydro 1H benzo[d]azepin 1 yl)amino) 1 oxopropan 2 yl)butanamide Smiles: CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O InChiKey: